Medical Billing RFP Services for Infectious Disease Practices

Medical billing RFP services help an infectious disease practice define its billing needs, evaluate prospective vendors, and compare capabilities against the practice’s actual workflows. Relevant areas may include E/M and consult claims, infusion and drug billing, OPAT, eligibility, authorization, denials, underpayments, A/R, payer contracts, reporting, and system support. A strong RFP makes these requirements explicit rather than relying on generic billing language.

Infectious disease revenue cycles can combine cognitive services with infusion, OPAT, drug acquisition, administration, hospital coverage, and payer requirements. These elements create billing and workflow questions that may not be addressed by a general medical billing proposal. Specialized evaluation helps practices determine whether a vendor understands documentation, coding, benefit distinctions, authorization, payment reconciliation, denials, and the relationship between clinical services and reimbursement.

An RFP should describe the practice’s service lines, systems, current workflow, claim types, payer mix where relevant, infusion or OPAT activity, authorization needs, denial processes, A/R expectations, reporting requirements, and responsibilities for coding or charge review. It should also request the vendor’s implementation approach, escalation process, communication structure, relevant experience, and method for identifying revenue leakage, while leaving practice-specific figures open for verification.

Billing support can be evaluated for infusion and OPAT services alongside office visits, hospital consults, and other infectious disease work. The RFP should clarify responsibility for drug claims, administration charges, authorization, medical versus pharmacy benefit questions, documentation review, claim submission, denials, and payment follow-up. Practices should ask vendors to explain how these workflows are coordinated and reported rather than assuming all services follow the same billing process.

Compare vendors against the same written requirements and ask for specific descriptions of their workflow, systems access, coding review, claim scrubbing, rejection handling, denial appeals, A/R follow-up, reporting, and escalation practices. For infectious disease practices, also compare their understanding of drug and infusion claims, OPAT, authorization, payer contracts, and hospital-related arrangements. Review how each proposal separates verified capabilities from assumptions or estimates.

Common areas for investigation include under-leveled visits, missing drug or administration charges, authorization gaps, medical-versus-pharmacy benefit confusion, coding errors, rejected claims, recurring denials, short-pays, incorrect fee schedule application, aging high-dollar claims, and unpursued balances. Reporting by payer, service line, and provider can help connect a financial result to its source in documentation, charge capture, contracts, or workflow.

GrowInfectiousDisease does not publish invented rates, drug acquisition costs, payment rates, or margin figures. Practices can apply their own numbers using practical guidance and browser-based tools. This approach keeps the analysis transparent and avoids treating generalized assumptions as facts. Vendor proposals, payer contracts, internal reports, and practice-specific financial data should be reviewed when a decision requires precise figures.

Gather a clear description of services, current billing and authorization workflows, systems in use, recurring denial categories, A/R reporting, payer and contract questions, staffing responsibilities, infusion or OPAT processes, and the outcomes the practice wants to improve. Identifying known gaps and unresolved questions before issuing the RFP helps vendors respond to the same requirements and gives practice leaders a stronger basis for evaluation.